Latest Breaking News On - Department of hematology hematopoietic cell transplantation - Page 7 : vimarsana.com

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMonzrm al malkiHeather savelleDebora bartonGavin macbeathAl malkiJoyce allaireDepartment of hematology hematopoietic cell transplantationGlobe newswire tscan therapeutics incLifesci advisorsAmerican society of hematology annual meetingTscan therapeutics incAmerican society of hematologySecurities exchangeTherapeutics presents initial phaseAmerican society

TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSan diego convention centerHeather savelleJoyce allaireNina abelowitzMonzrm al malkiJyun wangErica buonomoAasiya matinShrikanta chattopadhyayMonzr al malkiGavin macbeathJim murrayDebora bartonAl malki

Dr Danilov on the Investigation of BTK Degraders in CLL

Alexey Danilov, MD, PhD, discusses the investigation of BTK degraders in the treatment of chronic lymphocytic leukemia.

Alexey danilovDivision of leukemiaToni stephenson lymphoma center professorDepartment of hematology hematopoietic cell transplantationHematopoietic cell transplantationInternational workshop on cllOnclive tv

Primary Endpoint Met for Revumenib in Patients with AML and ALL

In the recent AUGMENT-101 trial, revumenib met the study goals of complete remission in patients with acute myeloid leukemia or acute lymphoid leukemia.

Ibrahim aldossMichaela metzgerDepartment of hematology hematopoietic cell transplantationDivision of leukemiaBreakthrough therapy designationHematopoietic cell transplantationAcute myeloid leukemiaAcute lymphoid leukemia

Dr Phillips on the Evolving Treatment Landscape in MCL

Tycel Phillips, MD, discusses current and emerging therapeutic treatment strategies for patients with mantle cell lymphoma.

Tycel phillipsDivision of lymphomaDepartment of hematology hematopoietic cell transplantationHematopoietic cell transplantationCity of hopePatients with mantle cell lymphoma